In a regulatory filing, Cue Biopharma (CUE) disclosed that on June 4, Kerri-Ann Millar notified the company that she is resigning from her position as Chief Financial Officer, effective June 13. Effective June 13, Daniel Passeri, the company’s Chief Executive Officer, will serve as the company’s principal financial and accounting officer on an interim basis until a new principal financial and accounting officer is designated, the filing stated.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CUE: